Results 71 to 80 of about 24,588 (279)

Obesity and Its Impact on Endoscopic Sinus Surgery Outcomes in Patients With Chronic Rhinosinusitis With Nasal Polyps

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Purpose The rising prevalence of obesity introduces challenges in surgical contexts, including endoscopic sinus surgery (ESS) for chronic rhinosinusitis with nasal polyps (CRSwNP). However, the impact of obesity on ESS outcomes remains underexplored. This study aims to evaluate the association between obesity and surgical complexity, operative
Hen Chaushu, Narin Nard Carmel Neiderman, Yuval Presman, Alexandra Dorman, Roni Vass, Nidal Muhanna, Avraham Abergel   +6 more
wiley   +1 more source

Krooniline urtikaaria [PDF]

, 2017
Krooniline urtikaaria on nahahaigus, mida iseloomustab kuplade esinemine nahal 6 nädala vältel või kauem. Enamikul juhtudel allub see hästi ravile uue põlvkonna H1-antihistamiinikumidega, kuid teatud juhtudel on vaja kasutada veel põletikuvastase või ...
Kaldvee, Bret, Karelson, Maire
core   +2 more sources

The Prevalence of Symptomatic Dermographism: Results of the International UCARE PREVALENCE‐D Study

Allergy, EarlyView.
An online expert‐designed questionnaire estimated the international prevalence of dermographism. Symptomatic dermographism, physiological red dermographism, and simple urticarial dermographism exhibit distinct prevalence patterns across age groups, sex, and geographic regions. Symptomatic dermographism has an international point prevalence of 3.20% (95%
Kanokvalai Kulthanan, Jonathan A. Bernstein, Michael Rudenko, Pascale Salameh, Chulaluk Komoltri, Esra Adışen, Salma Al Abri, Mona Al‐Ahmad, Nasser Al‐Ahmed, Bushra Al Hinai, Anastasiia Allenova, Saad Alshareef, Nattha Angkoolpakdeekul, Rand Arnaout, Joanna Bartosińska, Ivan Cherrez‐Ojeda, Leena Chularojanamontri, Paulo Ricardo Criado, Luis Felipe Ensina, Roberta Fachini Jardim Criado, Cesar Alberto Galvan Calle, Ana Maria Giménez‐Arnau, Kiran Godse, Maia Gotua, Naoko Inomata, Nuttagarn Jantanapornchai, Chang‐Gyu Jung, Alicja Kasperska‐Zając, Maryam Khoshkhui, Pavel Kolkhir, Dorota Krasowska, Jomgriditip Laomoleethorn, Antonina Maiorowa, Raisa Meshkova, Dragan Mijakoski, Melba Munoz, Yanisorn Nanchaipruek, Iman Nasr, Rabia Öztaş Kara, Waratchaya Panjapakkul, Teerapat Paringkarn, Indrashis Podder, Karla Robles‐Velasco, Isabel Rosmaninho, Ana Rita Presa, Chuda Rujitharanawong, Phuwakorn Saengthong‐aram, Rana Tafrishi, Natasa Teovska Mitrevska, Papapit Tuchinda, Teerapat Wannawittayapa, Anushka Wilson, Young‐Min Ye, Anna Zalewska‐Janowska, Marcus Maurer, Torsten Zuberbier   +55 more
wiley   +1 more source

Effectiveness and safety of omalizumab in patients with allergic bronchopulmonary aspergillosis with or without allergic rhinitis: a retrospective chart review

BMC Pulmonary Medicine, 2023
Background Omalizumab is a valuable alternative treatment for allergic bronchopulmonary aspergillosis (ABPA). The effectiveness and safety of this medication have not been confirmed.
Cuihong Cai, Jingjing Qu, Jianying Zhou
doaj   +1 more source

Omalizumab in IgE-Mediated Food Allergy: A Systematic Review and Meta-Analysis [PDF]

, 2022
Torsten Zuberbier, Robert A. Wood, Carsten Bindslev‐Jensen, Alessandro Fiocchi, R. Sharon Chinthrajah, Margitta Worm, A. Deschildre, Montserrat Fernández‐Rivas, Alexandra F. Santos, Xavier Jaumont, Paolo Tassinari   +10 more
openalex   +1 more source

Pharmacoeconomic analysis of using biological agents for uncontrolled moderate-to-severe atopic asthma in the Russian Federation

Фармакоэкономика, 2020
Objective – to conduct a pharmacoeconomic analysis of using omalizumab, mepolizumab and reslizumab in the treatment of patients with uncontrolled moderate and severe atopic asthma in the healthcare setting of the Russian Federation.Materials and Methods.
S. K. Zyryanov, I. N. Diyakov, S. N. Avdeev   +2 more
doaj   +1 more source

Atopic Dermatitis Anti-IgE Paediatric Trial (ADAPT): the role of anti-IgE in severe paediatric eczema: study protocol for a randomised controlled trial. [PDF]

, 2017
The evidence for systemic treatments for severe childhood eczema is limited and largely based on extrapolation of data from adult studies. Current therapies are often immunosuppressant and may be associated with both short- and long-term side effects ...
Chen, Tao
core   +1 more source

A Case of Palmoplantar Vesiculobullous Lesions

JEADV Clinical Practice, EarlyView.
Ali Abid, Kelvin Truong, Jing Jing Li, Artiene Tatian   +3 more
wiley   +1 more source

Decreased Severity of Oral Immunotherapy Induced Gastrointestinal Eosinophilic Reactions Following Revisions in Milk‐Treatment Protocol

Allergy, EarlyView.
A revised milk OIT protocol with lower daily allergen load and slower dose escalation reduced the severity and delayed onset of OIT‐induced gastrointestinal eosinophilic reactions (OITIGER). Elevated baseline absolute eosinophil count (AEC > 600/μL) was a consistent independent risk factor for OITIGER, while older age was protective.
Na'ama Epstein‐Rigbi, Matan Elkan, Yair Tzarfati, Michael B. Levy, Liat Nachshon, Yael Koren, Yitzhak Katz, Arnon Elizur, Michael R. Goldberg   +8 more
wiley   +1 more source

Omalizumab controls surface phenotypes of dendritic cells and monocytes in asthma

Journal of Allergy and Clinical Immunology: Global
Background: Omalizumab can provide clinical benefits to a fraction of moderate-to-severe asthma patients. However, the mechanisms of action of omalizumab have not been fully understood.
Agnes Yang, BS, Laurie Baert, PhD, Katherine Upchurch, PhD, Mark Millard, MD, Matthew Wiest, PhD, Chao Gu, PhD, HyeMee Joo, PhD, SangKon Oh, PhD   +7 more
doaj   +1 more source